GeneSort
GeneSort
Agent21Agent Readiness: 21/100. Bottom 25%. Measured by StartupHub.ai. Median 41.A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.
About
GeneSort was a molecular diagnostics company that focused on integrating molecular genomics with personalized therapeutic approaches. Its core technology leveraged patients' genetic DNA profiles to assist physicians in selecting tailored treatments, primarily for cancer and hereditary diseases. The company aimed to provide diagnostic services that helped oncologists adapt treatments to specific genetic mutations.
Key facts
At-a-glance profile data
- Website
- genesort.com
- Headquarters
- Tel Aviv, Israel
- Founded
- 2014
- Employees
- 4
- Total funding
- $2M
- Business model
- B2B
Add first review
Frequently asked
How much funding has GeneSort raised?
GeneSort has raised a total of $2M in funding.
How many employees does GeneSort have?
GeneSort has approximately 4 people on record.
What is GeneSort's current status?
GeneSort's current operating status is: Inactive.